MRNA Mar 2025 130.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:59PM EDT. Market open.
| Previous close | 37.50 |
| Open | 32.75 |
| Bid | 32.45 |
| Ask | 33.25 |
| Strike | 130.00 |
| Expiry date | 2025-03-21 |
| Day's range | 32.75 - 32.75 |
| Contract range | N/A |
| Volume | |
| Open interest | 48 |
ZacksModerna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Simply Wall St.Moderna (NASDAQ:MRNA) shareholders are still up 857% over 5 years despite pulling back 6.1% in the past week
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
Investor's Business DailyIs Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Moderna stock is trading sideways despite a bevy of news, including FDA approval for its RSV vaccine. Is MRNA stock a buy right now?
© 2024 Yahoo. All rights reserved.